Diagnostic Issues in Dementia: Neuroimaging as a Surrogate Marker of Disease
- 1 September 2006
- journal article
- review article
- Published by SAGE Publications in Journal of Geriatric Psychiatry and Neurology
- Vol. 19 (3), 180-185
- https://doi.org/10.1177/0891988706291089
Abstract
Structural neuroimaging is a routine component of the diagnostic evaluation of dementia that is used to rule out potential causes of mental impairment, whereas functional imaging can differentiate different forms of dementia. Neuroimaging also offers promise as a surrogate marker for clinical trials, and new technologies have been developed to provide measures of amyloid plaques and neurofibrillary tangles, the neuropathological hallmarks of Alzheimer’s disease. Combining imaging with genetic risk data will likely improve diagnostic accuracy. These new findings warrant reconsideration of current guidelines on the use of neuroimaging in diagnosis and research in dementia. ( J Geriatr Psychiatry Neurol 2006;19:180-185)Keywords
This publication has 36 references indexed in Scilit:
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Patterns of Brain Activation in People at Risk for Alzheimer's DiseaseNew England Journal of Medicine, 2000
- Genetic testing for Alzheimerʼs disease: how close is reality?Current Opinion in Psychiatry, 1999
- Clinical Value of Neuroimaging in the Diagnosis of Dementia Sensitivity and Specificity of Regional Cerebral Metabolic and Other Parameters for Early Identification of Alzheimer's DiseaseClinical Positron Imaging, 1999
- Amyloid probes based on Congo Red distinguish between fibrils comprising different peptidesCell Chemical Biology, 1996
- Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the ε4 Allele for Apolipoprotein ENew England Journal of Medicine, 1996
- Chrysamine-G binding to Alzheimer and control brain: Autopsy study of a new amyloid probeNeurobiology of Aging, 1995
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Reduced Cerebral Glucose Metabolism in Asymptomatic Subjects at Risk for Huntington's DiseaseNew England Journal of Medicine, 1987